4 But, when the authors combined six trials (including 785 patients) with a low risk of bias, a nonsignificant trend was seen for the reduction of VAP toward probiotics.
1
—
—
4 But, when the authors combined six trials (including 785 patients) with a low risk of bias, a nonsignificant trend was seen for the reduction of VAP toward probiotics.